Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor()

BACKGROUND: Preclinical and clinical studies have reported that human epidermal growth factor receptor 2 (HER2) overexpression yields resistance to endocrine therapies. Here the prevalence and prognostic impact of HER2-positive circulating tumor cells (CTCs) were investigated retrospectively in meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Beije, Nick, Onstenk, Wendy, Kraan, Jaco, Sieuwerts, Anieta M., Hamberg, Paul, Dirix, Luc Y., Brouwer, Anja, de Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Van, Ngoc M., Foekens, John A., Martens, John W.M., Sleijfer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071539/
https://www.ncbi.nlm.nih.gov/pubmed/27764697
http://dx.doi.org/10.1016/j.neo.2016.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071539/
https://www.ncbi.nlm.nih.gov/pubmed/27764697
http://dx.doi.org/10.1016/j.neo.2016.08.007

Ejemplares similares